Announcement
·
04 Jun 2024
·
Mumtalakat and M42 announce Amana Healthcare Bahrain expansion

Pharmaceutical manufacturing hub and bio-therapeutics projects in collaboration with Tier 1 pharma giants.

  • Robust manufacturing

    Access to robust manufacturing infrastructure to support national vision
  • Uniquely diverse datasets and capabilities

    Access to uniquely diverse datasets and capabilities through in-house clinical research arm
  • Co-owning research with pharma entities

    Co-owning research with pharma entities - initiating genomics R&D research
  • Building national disease registry

    Building national disease registry in the UAE

    Other Assets

      Digital Health

      AI-driven platforms covering the entire healthcare ecosystem and creating a continuous data loop.

      Advanced Diagnostics

      Built to address the need for population-scale detection and diagnosis of various infections.

      Multi-omics

      Omics Centre of Excellence is invested in the accentuated power of genomic, clinical and cross- disciplinary data that enables healthcare transformation...

      Environmental Sciences

      Providing predictive wastewater surveillance, advanced industrial testing, and comprehensive environmental tracking and reporting services through cutti...

      Clinical Research

      Accelerating drug and device development through comprehensive R&D, market access, commercialization, and regulatory support across all clinical trial p...